Biotek-snakken — April 2021
-
Tak Bioshare, interessant video. Min mave fornemmelse er ikke helt god med den ADCOM. Kan go se din pointe med at ph3 endpoint miss var en trial teknisk issue. bum bum e der ikke risiko for at de får em smal label for Quinolone Non-Susceptible
Population, kan man det ?. -
ZYME, tror shorterne bruger denne til at ryste træet. https://finance.yahoo.com/news/zymeworks-announces-succession-plan-chief-123000157.html
-
Ja OK præsentation. Meget fokus på pipeline og partnerskaber (back to basics), dog ikke noget om det partnerskab vi går og venter på med ZW25. Langt til nyheder. Lød som sidst på året for 2x GEA 1x Breast. Tror kursen er 100% renset for ZW49 forventninger, så det er måske tid til at supplere, da ZW265 burde kunne trække en del mere med de data.
-
Er Saniona ved at være interessant igen? Banker på ved SMA 200 og en del insiderkøb på det seneste. BRIEF-Saniona: Chairman, CEO And Additional Members Of The Board Purchase Shares In Co
-
ADDITIONAL MEMBERS OF THE BOARD AND MANAGEMENT PURCHASE SANIONA
SHARES
CHAIRMAN AND THE CEO, AS WELL AS ADDITIONAL MEMBERS OF THE
BOARD
OF DIRECTORS AND EXECUTIVE MANAGEMENT TEAM, HAVE PURCHASED
70,429 SHARES OF THE COMPANY IN THE OPEN MARKET FOR A TOTAL
VALUE OF APPROXIMATELY SEK 1.5 MILLION.
Hello! It looks like you're interested in this conversation, but you don't have an account yet.
Getting fed up of having to scroll through the same posts each visit? When you register for an account, you'll always come back to exactly where you were before, and choose to be notified of new replies (either via email, or push notification). You'll also be able to save bookmarks and upvote posts to show your appreciation to other community members.
With your input, this post could be even better 💗
Tilmeld Log ind